These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of amoxapine on serotonin uptake in human blood platelets of depressed patients and normal controls. Arora RC; Meltzer HY Psychiatry Res; 1983 May; 9(1):29-36. PubMed ID: 6577482 [TBL] [Abstract][Full Text] [Related]
7. Platelet imipramine binding in endogenous depressed patients and controls: relationship to platelet MAO and 5HT uptake during successful imipramine treatment. Quintana J Psychiatry Res; 1990 Sep; 33(3):229-42. PubMed ID: 2173840 [TBL] [Abstract][Full Text] [Related]
8. Model for the kinetics of imipramine and its metabolites in adolescents. Dell RB; Hein K; Ramakrishnan R; Puig-Antich J; Cooper T Ther Drug Monit; 1990 Sep; 12(5):450-9. PubMed ID: 2293407 [TBL] [Abstract][Full Text] [Related]
9. Platelet serotonin uptake dynamic changes in depression: effects of long-term imipramine treatment and clinical recovery. Quintana J J Affect Disord; 1989; 16(2-3):233-42. PubMed ID: 2522122 [TBL] [Abstract][Full Text] [Related]
10. Relationship between seasonal patterns of platelet serotonin uptake and 3H-imipramine binding in depressed patients and normal controls. Chicz-DeMet A; Reist C; DeMet EM Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):25-39. PubMed ID: 2008538 [TBL] [Abstract][Full Text] [Related]
11. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients. Sutfin TA; Perini GI; Molnar G; Jusko WJ J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999 [TBL] [Abstract][Full Text] [Related]
12. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors. Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276 [TBL] [Abstract][Full Text] [Related]
13. [Development of subsensitivity to imipramine in the system of reverse serotonin uptake by thrombocytes in patients with endogenous depression]. Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Faktor MI Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(9):96-100. PubMed ID: 3232463 [TBL] [Abstract][Full Text] [Related]
15. [Sensitivity of the retrograde uptake of H3-serotonin to imipramine and trazodone in patients with endogenous depression treated with antidepressive drugs]. Katasonov AB; Beliaev BS; Zlobina GP; Faktor MI; Brusov OS Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):125-8. PubMed ID: 2728713 [TBL] [Abstract][Full Text] [Related]
16. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine. Lemmer B; Holle L Chronobiol Int; 1991; 8(3):176-85. PubMed ID: 1794155 [TBL] [Abstract][Full Text] [Related]
17. Targeting imipramine dose in children with depression. Sallee F; Stiller R; Perel J; Rancurello M Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179 [TBL] [Abstract][Full Text] [Related]
18. Methodological issues in the preparation and assay of platelet 3H-imipramine binding. Severson JA; Schneider LS; Fredrickson ER Psychiatry Res; 1990 Jul; 33(1):19-29. PubMed ID: 1699244 [TBL] [Abstract][Full Text] [Related]
19. Response of depression to very high plasma levels of imipramine plus desipramine. Garvey M; DeRubeis RJ; Hollon SD; Evans MD; Tuason VB Biol Psychiatry; 1991 Jul; 30(1):57-62. PubMed ID: 1892963 [TBL] [Abstract][Full Text] [Related]
20. Platelet serotonin uptake inhibition as a basis for monitoring antidepressant drug treatment. Lingjaerde O J Clin Psychopharmacol; 1984 Apr; 4(2):76-81. PubMed ID: 6231316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]